These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19014906)

  • 1. Specific repression of mutant K-RAS by 10-23 DNAzyme: sensitizing cancer cell to anti-cancer therapies.
    Yu SH; Wang TH; Au LC
    Biochem Biophys Res Commun; 2009 Jan; 378(2):230-4. PubMed ID: 19014906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 10-23 DNAzyme to selectively destroy the allele of mRNA with a unique purine-pyrimidine dinucleotide.
    Wang TH; Li WT; Yu SH; Au LC
    Oligonucleotides; 2008 Sep; 18(3):295-9. PubMed ID: 18699741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
    Lam JC; Withers JB; Li Y
    J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new and efficient DNA enzyme for the sequence-specific cleavage of RNA.
    Feldman AR; Sen D
    J Mol Biol; 2001 Oct; 313(2):283-94. PubMed ID: 11800557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme.
    Liu C; Cheng R; Sun LQ; Tien P
    Biochem Biophys Res Commun; 2001 Jun; 284(4):1077-82. PubMed ID: 11409904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific cleavage of mutant ABL mRNA by DNAzyme is facilitated by peptide nucleic acid binding to RNA substrate.
    Kim JE; Yoon S; Mok H; Jung W; Kim DE
    FEBS Lett; 2012 Nov; 586(21):3865-9. PubMed ID: 23010596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAzyme-mediated silencing of ornithine decarboxylase.
    Ackermann JM; Kanugula S; Pegg AE
    Biochemistry; 2005 Feb; 44(6):2143-52. PubMed ID: 15697240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of a DNAzyme targeting c-myc to HT29 colon carcinoma cells using a gold nanoparticulate approach.
    Tack F; Noppe M; Van Dijck A; Dekeyzer N; Van Der Leede BJ; Bakker A; Wouters W; Janicot M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):221-5. PubMed ID: 18444511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
    Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
    J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.
    Tsang WP; Kwok TT
    Carcinogenesis; 2009 Jun; 30(6):953-9. PubMed ID: 19372139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two DNAzymes targeting the telomerase mRNA with large difference in Mg2+ concentration for maximal catalytic activity.
    Yuan BF; Xue Y; Luo M; Hao YH; Tan Z
    Int J Biochem Cell Biol; 2007; 39(6):1119-29. PubMed ID: 17499543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-site selection for the 10-23 DNAzyme.
    Cairns MJ; Sun LQ
    Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
    Reyes-Gutiérrez P; Alvarez-Salas LM
    Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the function of nucleotides in the catalytic cores of the 8-17 and 10-23 DNAzymes by abasic nucleotide and C3 spacer substitutions.
    Wang B; Cao L; Chiuman W; Li Y; Xi Z
    Biochemistry; 2010 Sep; 49(35):7553-62. PubMed ID: 20698496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras.
    Wilder PJ; Chakravarthy H; Hollingsworth MA; Rizzino A
    Biochem Biophys Res Commun; 2009 Apr; 381(4):706-11. PubMed ID: 19254697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research of 10-23 DNAZyme inhibit the expression of eIF4E genes].
    Teng B; Xin D; Wen L; Cui S; Jin C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jun; 21(12):552-4. PubMed ID: 17802829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.